Condition
Sex Chromosome Disorders
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Completed2
Enrolling By Invitation2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07341412Enrolling By InvitationPrimary
Clinical and Genetic Aspects in Fetuses and Children With Sex Chromosome Disorders
NCT07304193Enrolling By InvitationPrimary
Clinical and Genetic Aspects of Fetuses With Sex-chromosome Disorders
NCT03862950Phase 2Completed
A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
NCT03479476Phase 2Completed
A Trial of Metformin in Individuals With Fragile X Syndrome
NCT04189406Unknown
Turner Syndrome Minipuberty Study
Showing all 5 trials